Microcore is an R&D-driven biotech company specializing in the discovery, development, and manufacturing of clinically validated specialty nutraceuticals. Built on a strong scientific foundation and a commitment to innovation, Microcore delivers evidence-based solutions designed to address chronic and degenerative health conditions. Evolving from a research-focused organization into a fully integrated, innovation-led global enterprise, Microcore offers end-to-end expertise—from concept development and formulation to manufacturing and clinical validation. This integrated approach ensures that every product meets the highest standards of efficacy, safety, and regulatory compliance.

Microcore’s advanced nutraceutical portfolio targets a broad spectrum of health conditions, including Arthritis & Osteoarthritis, Osteoporosis & Osteopenia, Inflammatory Disorders, Rheumatoid Arthritis, Wound Healing & Tissue Regeneration, as well as Hair and Skin Health. Backed by GMP-certified manufacturing, robust clinical research, and a strong intellectual property portfolio, Microcore is dedicated to improving patient outcomes and enhancing quality of life through science-backed innovation.

In collaboration with leading hospitals and gastroenterologists, Microcore is actively advancing “Mucosal Healing Strategies in Non-Variceal Gastrointestinal Bleeding: A Research-Driven Perspective”, alongside ongoing clinical research initiatives in mucosal wound healing and regenerative therapies. A key focus area also includes the development of clinically oriented egg membrane–derived regenerative solutions for burn and traumatic wound healing, reinforcing its commitment to translational science and real-world clinical impact.